-
Assessing Accuracy of Unsupervised Large Language Model Tools for Identifying Key Criteria Supporting Abstract Screening
Sep 9, 2025, 16:22 PM -
Implementing Coverage With Evidence Development for Medicines With Uncertain Clinical Benefit: Insights From the Netherlands
Sep 9, 2025, 16:22 PM -
From Development to Reimbursement Evidence-Generation Strategies for HealthTech in Europe
Sep 9, 2025, 16:22 PM -
A Review of Approaches to Select Instruments and Items to Measure Patient Reported Tolerability in Clinical Trials in Oncology
Sep 9, 2025, 16:22 PM -
Accessibility and Time to Reimbursement of Treatments With Substantial Benefit: A Comparative Analysis Focused on Inequalities Between Different European Countries and Different Tumor Types
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Composite Materials for Hard Dental Tissue Defect Restorations From Budget Financing in Wartime in Ukraine
Sep 9, 2025, 16:22 PM -
Health Utilities Among Patients With Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial
Sep 9, 2025, 16:22 PM -
Exploring Knowledge Attitudes and Perspectives on Respiratory Viruses Vaccination Among Older Adults in the US
Sep 9, 2025, 16:22 PM -
Comparative Efficacy and Safety of Avacincaptad Pegol vs. Pegcetacoplan in Treatment of Geographic Atrophy: Insights From a Multilevel Network Meta-Regression
Sep 9, 2025, 16:22 PM -
Calibrating Large Language Model Probabilities to Achieve Target Recall in Systematic Review Screening
Sep 9, 2025, 16:22 PM -
What Characteristics Are Associated With Having a Work Limitation Among United States Adults With Asthma?
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use in Uncontrolled Hypertension: An Observational Study in England Using Electronic Health Records
Sep 9, 2025, 16:22 PM -
Enhancing Targeted Literature Reviews (TLRs) with Artificial Intelligence (AI): A Methodological Approach for Conducting Efficient Targeted Searches
Sep 9, 2025, 16:22 PM -
Tatooheene: An R Package for Health Economic Evaluations Aligned With Dutch Costing Guidelines
Sep 9, 2025, 16:22 PM -
Economic Evaluations Cost and Resource Utilization in Early Triple-Negative and Low Hormone Receptor-Positive Breast Cancer: A Comprehensive Systematic Review
Sep 9, 2025, 16:22 PM -
Budget Impact of Metyrapone for the Treatment of Cushing’s Syndrome in France
Sep 9, 2025, 16:22 PM -
Automating PICOs Criteria Assessment in Systematic Reviews With LLMs: Insights From Two Case Studies
Sep 9, 2025, 16:22 PM -
First-Line Immunotherapies for Advanced Biliary Tract Cancer: A Systematic Review of Economic Studies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Delgocitinib vs. PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of Orphan Drugs in France: Key Insights from CEESP Reviews (2021-2024)
Sep 9, 2025, 16:22 PM